Biotech Medics Ne
BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrat… Read more
Biotech Medics Ne (BMCS) - Total Liabilities
Latest total liabilities as of March 2025: $441.14K USD
Based on the latest financial reports, Biotech Medics Ne (BMCS) has total liabilities worth $441.14K USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Biotech Medics Ne - Total Liabilities Trend (2008–2024)
This chart illustrates how Biotech Medics Ne's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Biotech Medics Ne Competitors by Total Liabilities
The table below lists competitors of Biotech Medics Ne ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
UMC Inc
PINK:UMCN
|
USA | $14.68K |
|
Real Estate Credit Investments Limited
LSE:RECI
|
UK | GBX117.51 Million |
|
MALACHITE RESOURCES
BE:MUW
|
Germany | €53.96 Million |
|
Baker Steel Resources Trust
LSE:BSRT
|
UK | GBX146.36K |
|
Puma VCT 13 PLC
LSE:PU13
|
UK | GBX844.00K |
|
AHLERS - Dusseldorf Stock Exchang
DU:AAH
|
Germany | €105.97 Million |
|
Aeon Ventures Inc
PINK:IDEA
|
USA | $147.25K |
Liability Composition Analysis (2008–2024)
This chart breaks down Biotech Medics Ne's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biotech Medics Ne's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biotech Medics Ne (2008–2024)
The table below shows the annual total liabilities of Biotech Medics Ne from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $437.69K | +1.37% |
| 2023-12-31 | $431.78K | +1.34% |
| 2022-12-31 | $426.06K | +30.02% |
| 2021-12-31 | $327.69K | +75.08% |
| 2020-12-31 | $187.16K | +74.74% |
| 2019-12-31 | $107.11K | +134.34% |
| 2018-12-31 | $45.71K | 0.00% |
| 2017-12-31 | $45.71K | 0.00% |
| 2016-12-31 | $45.71K | 0.00% |
| 2015-12-31 | $45.71K | -97.74% |
| 2011-12-31 | $2.02 Million | +30.24% |
| 2010-12-31 | $1.55 Million | -76.69% |
| 2008-12-31 | $6.66 Million | -- |